chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Intermenstrual bleeding, Menstruation delayed, Night sweats, Pollakiuria
Clinical narrative: spotting consisting of dark brown discharge; extreme dryness when she attempted to insert a tampon; hot, hot sweating at night; flashes/hot, hot sweating at night; constant peeing; did not get her monthly period; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION DELAYED (did not get her monthly period), NIGHT SWEATS (hot, hot sweating at night), HOT FLUSH (flashes/hot, hot sweating at night), POLLAKIURIA (constant peeing) and INTERMENSTRUAL BLEEDING (spotting consisting of dark brown discharge) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder NOS.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced MENSTRUATION DELAYED (did not get her monthly period). In May 2021, the patient experienced NIGHT SWEATS (hot, hot sweating at night), HOT FLUSH (flashes/hot, hot sweating at night) and POLLAKIURIA (constant peeing). In August 2021, the patient experienced INTERMENSTRUAL BLEEDING (spotting consisting of dark brown discharge) and VULVOVAGINAL DRYNESS (extreme dryness when she attempted to insert a tampon). At the time of the report, MENSTRUATION DELAYED (did not get her monthly period) was resolving and NIGHT SWEATS (hot, hot sweating at night), HOT FLUSH (flashes/hot, hot sweating at night), POLLAKIURIA (constant peeing), INTERMENSTRUAL BLEEDING (spotting consisting of dark brown discharge) and VULVOVAGINAL DRYNESS (extreme dryness when she attempted to insert a tampon) outcome was unknown.            No concomitant medications were reported. No treatment information was provided
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vulvovaginal dryness
Clinical narrative: spotting consisting of dark brown discharge; extreme dryness when she attempted to insert a tampon; hot, hot sweating at night; flashes/hot, hot sweating at night; constant peeing; did not get her monthly period; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION DELAYED (did not get her monthly period), NIGHT SWEATS (hot, hot sweating at night), HOT FLUSH (flashes/hot, hot sweating at night), POLLAKIURIA (constant peeing) and INTERMENSTRUAL BLEEDING (spotting consisting of dark brown discharge) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder NOS.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021, the patient experienced MENSTRUATION DELAYED (did not get her monthly period). In May 2021, the patient experienced NIGHT SWEATS (hot, hot sweating at night), HOT FLUSH (flashes/hot, hot sweating at night) and POLLAKIURIA (constant peeing). In August 2021, the patient experienced INTERMENSTRUAL BLEEDING (spotting consisting of dark brown discharge) and VULVOVAGINAL DRYNESS (extreme dryness when she attempted to insert a tampon). At the time of the report, MENSTRUATION DELAYED (did not get her monthly period) was resolving and NIGHT SWEATS (hot, hot sweating at night), HOT FLUSH (flashes/hot, hot sweating at night), POLLAKIURIA (constant peeing), INTERMENSTRUAL BLEEDING (spotting consisting of dark brown discharge) and VULVOVAGINAL DRYNESS (extreme dryness when she attempted to insert a tampon) outcome was unknown.            No concomitant medications were reported. No treatment information was provided
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pain
Clinical narrative: my arm where I got the vaccine is hard and painful to the touch; my arm where I got the vaccine is hard and painful to the touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (my arm where I got the vaccine is hard and painful to the touch) and VACCINATION SITE PAIN (my arm where I got the vaccine is hard and painful to the touch) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, the patient experienced VACCINATION SITE INDURATION (my arm where I got the vaccine is hard and painful to the touch) and VACCINATION SITE PAIN (my arm where I got the vaccine is hard and painful to the touch). At the time of the report, VACCINATION SITE INDURATION (my arm where I got the vaccine is hard and painful to the touch) and VACCINATION SITE PAIN (my arm where I got the vaccine is hard and painful to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported. Treatment information were not provided.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: patient received a third Moderna dose of an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received a third Moderna dose of an expired vaccine) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Sep-2021 at 10:31 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021 at 10:31 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received a third Moderna dose of an expired vaccine). On 16-Sep-2021 at 10:31 AM, EXPIRED PRODUCT ADMINISTERED (patient received a third Moderna dose of an expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Medication was provided. No treatment  was provided. On 16/Sep/2021, a nursing supervisor reported that the vial had been punctured at 10:41 AM on 15/Sep/2021 and stored in refrigerator for the interim administered at 10:31 AM, 16/Sep/2021. A punctured vial was administered just under 12 hours past expiration.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Gait disturbance, Hypoaesthesia, Paraesthesia, Peripheral coldness
Clinical narrative: Hands are still cold and numb,feet have remained ice cold,[feet] feel a little cold; Really hurts to walk; Pins and needles; she was really cold; Feet and hands went numb; They were a little blue and purplish hasn't gotten better,[hands] turning a little blue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (she was really cold), HYPOAESTHESIA (Feet and hands went numb), SKIN DISCOLOURATION (They were a little blue and purplish hasn't gotten better,[hands] turning a little blue), PERIPHERAL COLDNESS (Hands are still cold and numb,feet have remained ice cold,[feet] feel a little cold) and GAIT DISTURBANCE (Really hurts to walk) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0481217 and 939902) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021 at 6:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Sep-2021, the patient experienced FEELING COLD (she was really cold), HYPOAESTHESIA (Feet and hands went numb) and SKIN DISCOLOURATION (They were a little blue and purplish hasn't gotten better,[hands] turning a little blue). On 16-Sep-2021, the patient experienced PERIPHERAL COLDNESS (Hands are still cold and numb,feet have remained ice cold,[feet] feel a little cold) and PARAESTHESIA (Pins and needles). 16-Sep-2021, the patient experienced GAIT DISTURBANCE (Really hurts to walk). At the time of the report, FEELING COLD (she was really cold), HYPOAESTHESIA (Feet and hands went numb), SKIN DISCOLOURATION (They were a little blue and purplish hasn't gotten better,[hands] turning a little blue), PERIPHERAL COLDNESS (Hands are still cold and numb,feet have remained ice cold,[feet] feel a little cold), GAIT DISTURBANCE (Really hurts to walk) and PARAESTHESIA (Pins and needles) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration
Clinical narrative: Hands are still cold and numb,feet have remained ice cold,[feet] feel a little cold; Really hurts to walk; Pins and needles; she was really cold; Feet and hands went numb; They were a little blue and purplish hasn't gotten better,[hands] turning a little blue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (she was really cold), HYPOAESTHESIA (Feet and hands went numb), SKIN DISCOLOURATION (They were a little blue and purplish hasn't gotten better,[hands] turning a little blue), PERIPHERAL COLDNESS (Hands are still cold and numb,feet have remained ice cold,[feet] feel a little cold) and GAIT DISTURBANCE (Really hurts to walk) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0481217 and 939902) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021 at 6:30 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Sep-2021, the patient experienced FEELING COLD (she was really cold), HYPOAESTHESIA (Feet and hands went numb) and SKIN DISCOLOURATION (They were a little blue and purplish hasn't gotten better,[hands] turning a little blue). On 16-Sep-2021, the patient experienced PERIPHERAL COLDNESS (Hands are still cold and numb,feet have remained ice cold,[feet] feel a little cold) and PARAESTHESIA (Pins and needles). 16-Sep-2021, the patient experienced GAIT DISTURBANCE (Really hurts to walk). At the time of the report, FEELING COLD (she was really cold), HYPOAESTHESIA (Feet and hands went numb), SKIN DISCOLOURATION (They were a little blue and purplish hasn't gotten better,[hands] turning a little blue), PERIPHERAL COLDNESS (Hands are still cold and numb,feet have remained ice cold,[feet] feel a little cold), GAIT DISTURBANCE (Really hurts to walk) and PARAESTHESIA (Pins and needles) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Lower oxygen level; Appetite lost; Arm hurts; Nauseous; Horrible headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of OXYGEN SATURATION DECREASED (Lower oxygen level), DECREASED APPETITE (Appetite lost), MYALGIA (Arm hurts), NAUSEA (Nauseous) and HEADACHE (Horrible headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 04IL20A and 04IL20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Anaphylaxis, Hypersensitivity, Urticaria, Asthma, Hay fever, Asthma in 2000 and Arthritis in 2000. Concurrent medical conditions included Fatigue extreme since March 2020, Throat tightness, Hearing impaired, Numb lips, Palpitation, Chest tightness, Hemiparesis and Stomach cramps. Concomitant products included CLINDAMYCIN from 2020 to an unknown date for Chest tightness, QVAR from 2012 to an unknown date for Chest tightness and Palpitations, XIIDRA 590 for Dry eye, MAGNESIUM and VITAMIN B2 for Hearing impaired, IBUPROFEN from 1990 to an unknown date for Stomach cramps and Hemiparesis, SYNTHROID, Lansporazole, LISINOPRIL, BREO, FISH OIL, CENTRUM SILVER, BUPROPION, VITAMIN D2 and AZITHROMYCIN (AZASITE) for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced OXYGEN SATURATION DECREASED (Lower oxygen level), DECREASED APPETITE (Appetite lost), MYALGIA (Arm hurts), NAUSEA (Nauseous), HEADACHE (Horrible headache) and FATIGUE (Fatigue). At the time of the report, OXYGEN SATURATION DECREASED (Lower oxygen level), DECREASED APPETITE (Appetite lost), MYALGIA (Arm hurts), NAUSEA (Nauseous), HEADACHE (Horrible headache) and FATIGUE (Fatigue) outcome was unknown.            No treatment medication information was provided. No concomitant medication information was provided.   This case was linked to MOD-2021-054570 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased
Clinical narrative: Lower oxygen level; Appetite lost; Arm hurts; Nauseous; Horrible headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of OXYGEN SATURATION DECREASED (Lower oxygen level), DECREASED APPETITE (Appetite lost), MYALGIA (Arm hurts), NAUSEA (Nauseous) and HEADACHE (Horrible headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 04IL20A and 04IL20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Anaphylaxis, Hypersensitivity, Urticaria, Asthma, Hay fever, Asthma in 2000 and Arthritis in 2000. Concurrent medical conditions included Fatigue extreme since March 2020, Throat tightness, Hearing impaired, Numb lips, Palpitation, Chest tightness, Hemiparesis and Stomach cramps. Concomitant products included CLINDAMYCIN from 2020 to an unknown date for Chest tightness, QVAR from 2012 to an unknown date for Chest tightness and Palpitations, XIIDRA 590 for Dry eye, MAGNESIUM and VITAMIN B2 for Hearing impaired, IBUPROFEN from 1990 to an unknown date for Stomach cramps and Hemiparesis, SYNTHROID, Lansporazole, LISINOPRIL, BREO, FISH OIL, CENTRUM SILVER, BUPROPION, VITAMIN D2 and AZITHROMYCIN (AZASITE) for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced OXYGEN SATURATION DECREASED (Lower oxygen level), DECREASED APPETITE (Appetite lost), MYALGIA (Arm hurts), NAUSEA (Nauseous), HEADACHE (Horrible headache) and FATIGUE (Fatigue). At the time of the report, OXYGEN SATURATION DECREASED (Lower oxygen level), DECREASED APPETITE (Appetite lost), MYALGIA (Arm hurts), NAUSEA (Nauseous), HEADACHE (Horrible headache) and FATIGUE (Fatigue) outcome was unknown.            No treatment medication information was provided. No concomitant medication information was provided.   This case was linked to MOD-2021-054570 (Patient Link).
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Second dose give on 14th day; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose give on 14th day) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939901 and 939902) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose give on 14th day). On 01-Sep-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose give on 14th day) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment information was reported.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Pain, Rash pruritic
Clinical narrative: Burns; Very painful; Rash from head to toe that itches; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Rash from head to toe that itches), BURNING SENSATION (Burns) and PAIN (Very painful) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH PRURITIC (Rash from head to toe that itches). On an unknown date, the patient experienced BURNING SENSATION (Burns) and PAIN (Very painful). At the time of the report, RASH PRURITIC (Rash from head to toe that itches), BURNING SENSATION (Burns) and PAIN (Very painful) had not resolved.            No concomitant product use was provided by the reporter. No treatment medication was provided.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amenorrhoea
Clinical narrative: Cessation of menstruation
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Exfoliative rash, Rash, Rash pruritic, Urticaria
Clinical narrative: 2nd week following vaccination I noticed rash on face. Appears dry and scaly and burns. Days later rash appears on my right arm and looks likes hives. Both rashes are still there  topical creams or allergy medicine helps. Both are very itchy.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Echocardiogram normal, Electrocardiogram normal, Fibrin D dimer normal, Intensive care
Clinical narrative: Pt was seen in the ER for chest pain, troponin noted to be elevated. EKG were normal. Pt was admitted to pediatric cardiac ICU for serial troponin and EKG checks. Troponin downtrending and pt was discharged after 48hrs.  Echocardiogram was normal.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin increased
Clinical narrative: Pt was seen in the ER for chest pain, troponin noted to be elevated. EKG were normal. Pt was admitted to pediatric cardiac ICU for serial troponin and EKG checks. Troponin downtrending and pt was discharged after 48hrs.  Echocardiogram was normal.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: tingling/numbness in left arm all the way to the hand
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Fatigue, Headache, Ocular hyperaemia, Pyrexia
Clinical narrative: Fatigue slight fever mild headache, chest pressure, red eyes
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to allopathic drugs (allergy to biaxin), Allergy to allopathic drugs (allergy to macrodantin), Allergy to allopathic drugs (allergy to azithromycin), Allergy to allopathic drugs (allergy to vantin), Allergy to allopathic drugs (allergy to travatan) and Allergy to allopathic drugs (allergy to eyedrops). Concomitant products included GABAPENTIN, TIZANIDINE HCL and EZETIMIBE for an unknown indication.    On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.         This case was linked to MOD-2021-307848, MOD-2021-320985 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Myalgia, Trigger finger, Vaccination site erythema, Vaccination site swelling
Clinical narrative: injection site redness; injection site heat; area around the injection was raised; sore arm; left thumb locked,having problems with her left thumb; move left thumb with some discomfort; This spontaneous case was reported by a nurse and describes the occurrence of MYALGIA (sore arm), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE WARMTH (injection site heat), VACCINATION SITE SWELLING (area around the injection was raised) and TRIGGER FINGER (left thumb locked,having problems with her left thumb) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939906) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypercholesteremia, Facial spasm (right facial spasms since the shingles ) and Nerve damage (She did have shingles of the trigeminal nerve and had post traumatic nerve damage around her eye). Concomitant products included BOTULINUM TOXIN TYPE A (BOTOX) for Facial spasm, ATORVASTATIN CALCIUM (LIPITOR) for Hypercholesteraemia, GABAPENTIN (GRALISE) for an unknown indication.    On 11-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Sep-2021, the patient experienced MYALGIA (sore arm). On 12-Sep-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE WARMTH (injection site heat) and VACCINATION SITE SWELLING (area around the injection was raised). In September 2021, the patient experienced TRIGGER FINGER (left thumb locked,having problems with her left thumb) and DISCOMFORT (move left thumb with some discomfort). On 14-Sep-2021, MYALGIA (sore arm), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE WARMTH (injection site heat) and VACCINATION SITE SWELLING (area around the injection was raised) outcome was unknown. At the time of the report, TRIGGER FINGER (left thumb locked,having problems with her left thumb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   She also got sick after the Shingrix vaccine. no treatment medications were provided
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: injection site redness; injection site heat; area around the injection was raised; sore arm; left thumb locked,having problems with her left thumb; move left thumb with some discomfort; This spontaneous case was reported by a nurse and describes the occurrence of MYALGIA (sore arm), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE WARMTH (injection site heat), VACCINATION SITE SWELLING (area around the injection was raised) and TRIGGER FINGER (left thumb locked,having problems with her left thumb) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939906) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypercholesteremia, Facial spasm (right facial spasms since the shingles ) and Nerve damage (She did have shingles of the trigeminal nerve and had post traumatic nerve damage around her eye). Concomitant products included BOTULINUM TOXIN TYPE A (BOTOX) for Facial spasm, ATORVASTATIN CALCIUM (LIPITOR) for Hypercholesteraemia, GABAPENTIN (GRALISE) for an unknown indication.    On 11-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Sep-2021, the patient experienced MYALGIA (sore arm). On 12-Sep-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE WARMTH (injection site heat) and VACCINATION SITE SWELLING (area around the injection was raised). In September 2021, the patient experienced TRIGGER FINGER (left thumb locked,having problems with her left thumb) and DISCOMFORT (move left thumb with some discomfort). On 14-Sep-2021, MYALGIA (sore arm), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE WARMTH (injection site heat) and VACCINATION SITE SWELLING (area around the injection was raised) outcome was unknown. At the time of the report, TRIGGER FINGER (left thumb locked,having problems with her left thumb) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   She also got sick after the Shingrix vaccine. no treatment medications were provided
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Flushing, Headache, Pyrexia, Rash
Clinical narrative: she unusually broke out with flushed skin for 10 minutes.; i broke out red like heat rash; still get fever; light headache; still get fever and chills; This spontaneous case was reported by a consumer and describes the occurrence of MILIARIA (i broke out red like heat rash), FLUSHING (she unusually broke out with flushed skin for 10 minutes.), PYREXIA (still get fever), HEADACHE (light headache) and CHILLS (still get fever and chills) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination.     Concomitant products included MULTIVITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;FOLIC ACID;NICOTINAMIDE;PANTHENOL;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE], VITAMIN C [ASCORBIC ACID] and PROGESTERONE for an unknown indication.    On 29-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Aug-2021, the patient experienced PYREXIA (still get fever), HEADACHE (light headache) and CHILLS (still get fever and chills). On 11-Sep-2021, the patient experienced MILIARIA (i broke out red like heat rash) and FLUSHING (she unusually broke out with flushed skin for 10 minutes.). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 11-Sep-2021, MILIARIA (i broke out red like heat rash) and FLUSHING (she unusually broke out with flushed skin for 10 minutes.) had resolved. At the time of the report, PYREXIA (still get fever), HEADACHE (light headache) and CHILLS (still get fever and chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient went to the doctor and blood work up done and Still waiting for the result   Most recent FOLLOW-UP information incorporated above includes: On 21-Sep-2021: Follow up received with event outcome recovered /resolved , in initial version Treatment was not captured .which is captured now .
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: spontaneous nose bleed for over a week; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (spontaneous nose bleed for over a week) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Nasal operation (vessel that was bleeding was so far up in the nose that couldn't be cauterized).   In March 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced EPISTAXIS (spontaneous nose bleed for over a week). At the time of the report, EPISTAXIS (spontaneous nose bleed for over a week) outcome was unknown.            No concomitant medication was reported No treatment medication was reported.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Did not receive second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Did not receive second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Did not receive second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Did not receive second dose) had resolved.            No concomitant medication was reported. No treatment information was provided. Consumer reported no symptoms from the first dose, he mentioned he was lazy and did not want to get second dose.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: 1st dose 07Apr2021, no 2nd dose yet; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (1st dose 07Apr2021, no 2nd dose yet) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (1st dose 07Apr2021, no 2nd dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (1st dose 07Apr2021, no 2nd dose yet) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment information was provided.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure measurement, Dizziness, Hyperhidrosis, Pain in extremity, Vision blurred
Clinical narrative: Pain in the hand; Started seeing blurred or black; sweated a lot; Felt dizzy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the hand), VISION BLURRED (Started seeing blurred or black), HYPERHIDROSIS (sweated a lot) and DIZZINESS (Felt dizzy) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040CZ1A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in the hand). an unknown date, the patient experienced VISION BLURRED (Started seeing blurred or black), HYPERHIDROSIS (sweated a lot) and DIZZINESS (Felt dizzy). At the time of the report, PAIN IN EXTREMITY (Pain in the hand) had not resolved and VISION BLURRED (Started seeing blurred or black), HYPERHIDROSIS (sweated a lot) and DIZZINESS (Felt dizzy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: low (Low) Blood pressure fell.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. It was reported that Patient was treated with Water and events got improved.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Inappropriate schedule of product administration, Migraine, Nausea
Clinical narrative: She was advised to get the second dose at least 90 days after the transfusion; stomach feels like there is a parasite; intense migraines that is felt more on the right side of the head, States that it starts from the front going to the back/migraines are so severe she can barely open her eyes and she can no longer work; very bad nausea/nausea spells; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach feels like there is a parasite), MIGRAINE (intense migraines that is felt more on the right side of the head, States that it starts from the front going to the back/migraines are so severe she can barely open her eyes and she can no longer work), NAUSEA (very bad nausea/nausea spells) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She was advised to get the second dose at least 90 days after the transfusion) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Sep-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach feels like there is a parasite), MIGRAINE (intense migraines that is felt more on the right side of the head, States that it starts from the front going to the back/migraines are so severe she can barely open her eyes and she can no longer work) and NAUSEA (very bad nausea/nausea spells). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She was advised to get the second dose at least 90 days after the transfusion). At the time of the report, ABDOMINAL DISCOMFORT (stomach feels like there is a parasite), MIGRAINE (intense migraines that is felt more on the right side of the head, States that it starts from the front going to the back/migraines are so severe she can barely open her eyes and she can no longer work) and NAUSEA (very bad nausea/nausea spells) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (She was advised to get the second dose at least 90 days after the transfusion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   She taking pain medications that were prescribed by her doctor   This case was linked to MOD-2021-321028 (Patient Link).
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Inappropriate schedule of product administration
Clinical narrative: Administration date of Moderna vaccine; previously received 1 dose of a approved vaccine (Covaxin); This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Sep-2021 and was forwarded to Moderna on 16-Sep-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (previously received 1 dose of an approved vaccine (Covaxin)) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (previously received 1 dose of an approved vaccine (Covaxin)). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (previously received 1 dose of an approved vaccine (Covaxin)) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant Medication was provided.  No treatment medication was provided.   This case was linked to MOD-2021-320340 (CROSSLINK TO ORIGINAL CASE MOD21-14409), MOD-2021-320876 (Patient Link).
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Administration date of Moderna vaccine past the BUD; Product storage error for vaccine kept in storage >30days; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine past the BUD) and PRODUCT STORAGE ERROR (Product storage error for vaccine kept in storage >30days) in a 27-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine past the BUD) and PRODUCT STORAGE ERROR (Product storage error for vaccine kept in storage >30days). On 09-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine past the BUD) and PRODUCT STORAGE ERROR (Product storage error for vaccine kept in storage >30days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment medications were provided.   This case was linked to MOD-2021-320876 (Patient Link).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Arms, legs and head started shaking so rapidly up in the air; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Arms, legs and head started shaking so rapidly up in the air) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016MZ0A and 029L20A) for COVID-19 vaccination.     The patient's past medical history included Suspected COVID-19 (She possibly had covid-19 in march 2020 and was on oxygen for 2 months.) in March 2020 and Oxygen therapy (Was on oxygen for 2 months.) in March 2020. Concurrent medical conditions included Penicillin allergy, Allergy to antibiotic and Drug allergy (Allergic to most of the medications including antibiotics and many more.).   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TREMOR (Arms, legs and head started shaking so rapidly up in the air) (seriousness criterion hospitalization). On 14-Feb-2021, TREMOR (Arms, legs and head started shaking so rapidly up in the air) had resolved.            Concomitant product use was not provider by the reporter.  Treatment included unspecified pain medication, shots and IV fluids.  Patient started to experience event by 11 PM on 13 Feb 2021 and patient was presented at emergency room and by 7 AM next morning patient experienced same event and admitted at the hospital for 7-8 hours.  Company comment: This case concerns a 74-year-old female patient with relevant medical history of covid-19 (March 2020) and Allergic to most of the medications who experienced serious, unlisted event of tremors. The event occurred same day after 2nd dose of Moderna COVID-19 Vaccine.  The events were considered related to the product by the reporter. The rechallenge was not applicable as the event occurred after the 2nd dose. The history of "Allergic to most of the medications" may remain a confounder. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.   This case was linked to MOD-2021-321057 (Patient Link).; Sender's Comments: This case concerns a 74-year-old female patient with relevant medical history of covid-19 (March 2020) and Allergic to most of the medications who experienced serious, unlisted event of tremors. The event occurred same day after 2nd dose of Moderna COVID-19 Vaccine.  The events were considered related to the product by the reporter. The rechallenge was not applicable as the event occurred after the 2nd dose. The history of "Allergic to most of the medications" may remain a confounder. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Interchange of vaccine products
Clinical narrative: previously received a complete series of COVID-19 vaccine; Administration date of Moderna vaccine past the BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine past the BUD) and INTERCHANGE OF VACCINE PRODUCTS (previously received a complete series of COVID-19 vaccine) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine past the BUD). On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (previously received a complete series of COVID-19 vaccine). On 13-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine past the BUD) had resolved. At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (previously received a complete series of COVID-19 vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.   This case was linked to MOD-2021-320876.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Disturbance in attention, Emotional distress, Feeling abnormal, Logorrhoea
Clinical narrative: became emotional; more outspoken; experiencing brain fog; hard time concentrating; This spontaneous case was reported by a consumer and describes the occurrence of EMOTIONAL DISTRESS (became emotional), LOGORRHOEA (more outspoken), FEELING ABNORMAL (experiencing brain fog) and DISTURBANCE IN ATTENTION (hard time concentrating) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Aug-2021, the patient experienced EMOTIONAL DISTRESS (became emotional), LOGORRHOEA (more outspoken), FEELING ABNORMAL (experiencing brain fog) and DISTURBANCE IN ATTENTION (hard time concentrating). At the time of the report, EMOTIONAL DISTRESS (became emotional), LOGORRHOEA (more outspoken), FEELING ABNORMAL (experiencing brain fog) and DISTURBANCE IN ATTENTION (hard time concentrating) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment medication were reported.   This case was linked to MOD-2021-321126 (Patient Link).
Age: 24.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administration date of Moderna vaccine past the BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine past the BUD) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine past the BUD). On 09-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administration date of Moderna vaccine past the BUD) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. Treatment information was not reported.   This case was linked to MOD-2021-320876 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Hyperhidrosis, Lymphadenopathy, Migraine, Myalgia
Clinical narrative: a massive migraine; sweats; every bone in my body ached, like I got hit by Mack truck; body aches; I have a lymph node on my right collarbone that looks like a goiter; This spontaneous case was reported by an other health care professional and describes the occurrence of MIGRAINE (a massive migraine), HYPERHIDROSIS (sweats), BONE PAIN (every bone in my body ached, like I got hit by Mack truck), MYALGIA (body aches) and LYMPHADENOPATHY (I have a lymph node on my right collarbone that looks like a goiter) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047C21A and 025B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Sep-2021, the patient experienced MIGRAINE (a massive migraine), HYPERHIDROSIS (sweats), BONE PAIN (every bone in my body ached, like I got hit by Mack truck), MYALGIA (body aches) and LYMPHADENOPATHY (I have a lymph node on my right collarbone that looks like a goiter). At the time of the report, MIGRAINE (a massive migraine), HYPERHIDROSIS (sweats), BONE PAIN (every bone in my body ached, like I got hit by Mack truck), MYALGIA (body aches) and LYMPHADENOPATHY (I have a lymph node on my right collarbone that looks like a goiter) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  No treatment information was provided.